RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast can...
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024
Project: PLEIO-RANK
Updated at: 27-04-2024